| Literature DB >> 25539953 |
Antonio M Rezende, Ludmila A Assis, Eduardo C Nunes, Tamara D da Costa Lima, Fabricio K Marchini, Eden R Freire, Christian R S Reis, Osvaldo P de Melo Neto1.
Abstract
BACKGROUND: The initiation of translation in eukaryotes is supported by the action of several eukaryotic Initiation Factors (eIFs). The largest of these is eIF3, comprising of up to thirteen polypeptides (eIF3a through eIF3m), involved in multiple stages of the initiation process. eIF3 has been better characterized from model organisms, but is poorly known from more diverged groups, including unicellular lineages represented by known human pathogens. These include the trypanosomatids (Trypanosoma and Leishmania) and other protists belonging to the taxonomic supergroup Excavata (Trichomonas and Giardia sp.).Entities:
Mesh:
Substances:
Year: 2014 PMID: 25539953 PMCID: PMC4320536 DOI: 10.1186/1471-2164-15-1175
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Summary of the search data for eIF3 subunits from the twelve organisms selected for this study
| Subunit |
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
The letter X means presence while empty box means absence in the various species, according to the bioinformatic analysis. X symbol indicates the eIF3f homologues identified only after the biochemical analysis of the Leishmania eIF3 complex.
General features for each eIF3 subunit found from , , and
| eIF3 subunit | (TriTrypDB) accession | Size (MW –KDa) | Comparison with human homologue | Gene product description at TriTrypDB | |
|---|---|---|---|---|---|
| % Identity (similarity) | % Query coverage | ||||
| eIF3a | LmjF.17.0010 | 774 (87.6) | 20 (38) | 51 | Hypothetical protein, conserved |
| Tb927.7.6090 | 762 (88.2) | 22 (43) | 61 | Hypothetical protein, conserved | |
| eIF3b | LmjF.17.1290 | 709 (80.8) | 25 (42) | 64 | Translation initiation factor, putative |
| Tb927.5.2570 | 696 (79.8) | 22 (39) | 91 | Translation initiation factor, putative (EIF3B) | |
| TVAG_333940 | 608 (68.2) | 19 (40) | 96 | Eukaryotic translation initiation factor 3 subunit, putative | |
| GL50803_15495 | 871 (98.5) | 19 (37) | 55 | Hypothetical protein | |
| eIF3c | LmjF.36.6980 | 731 (82.0) | 24 (46) | 44 | Eukaryotic translation initiation factor 3 subunit 8, putative |
| Tb927.10.8270/ Tb927.10.8290 | 740 (84.3) | 24 (44) | 74 | Eukaryotic translation initiation factor 3 subunit 8, putative | |
| TVAG_184380 | 773 (90.0) | 26 (47) | 48 | Hypothetical protein | |
| GL50803_24279 | 793 (89.5) | 19 (39) | 21 | Hypothetical protein | |
| eIF3d | LmjF.30.3040 | 531 (60.6) | 24 (40) | 90 | Eukaryotic translation initiation factor 3 subunit 7-like, putative |
| 1 Tb927.6.4370 | 506 (57.9) | 29 (46) | 75 | Eukaryotic translation initiation factor 3 subunit 7-like, putative | |
| TVAG_062640 | 464 (52.8) | 25 (45) | 63 | Eukaryotic translation initiation factor 3 subunit, putative | |
| eIF3e | LmjF.28.2310 | 405 (46.4) | 28 (47) | 93 | Eukaryotic translation initiation factor subunit, putative |
| Tb927.11.11590 | 413 (46.7) | 27 (47) | 72 | Eukaryotic translation initiation factor subunit, putative | |
| eIF3f | LmjF.25.1610 | 326 (36.7) | 29 (50) | 27 | Hypothetical protein, conserved |
| Tb927.3.1680 | 318 (35.1) | 2~ | 10 | Hypothetical protein, conserved | |
| eIF3g | LmjF.34.2700 | 255 (28.8) | 26 (47) | 57 | Hypothetical protein, conserved |
| Tb927.4.1930 | 272 (31.3) | 23 (42) | 86 | RNA-binding protein, putative (EIF3D) | |
| eIF3h | LmjF.07.0640 | 335 (37.9) | 21 (45) | 65 | Hypothetical protein, conserved |
| Tb927.8.1170/ Tb927.8.1190 | 331 (36.4) | 22 (40) | 50 | Hypothetical protein, conserved | |
| TVAG_105990 | 329 (38.0) | 24 (44) | 82 | Eukaryotic translation initiation factor 3 subunit, putative | |
| eIF3i | 1LmjF.36.3880 | 352 (38.2) | 29 (50) | 96 | Eukaryotic translation initiation factor 3 subunit 2, putative |
| Tb927.11.9610 | 342 (37.7) | 38 (57) | 95 | Eukaryotic translation initiation factor 3 subunit 2, putative (eIF-3 beta) | |
| TVAG_114460 | 371 (41.5) | 27 (42) | 88 | Eukaryotic translation initiation factor 3 subunit, putative | |
| GL50803_13661 | 350 (38.4) | 24 (43) | 91 | Eukaryotic translation initiation factor 3 subunit 2 | |
| eIF3j | LmjF.25.2120 | 211 (23.5) | 22 (37) | 79 | Hypothetical protein, conserved |
| Tb927.3.2220 | 220 (23.8) | 25 (43) | 53 | Hypothetical protein, conserved | |
| GL50803_15546 | 261 (29.2) | 23 (40) | 98 | Hypothetical protein | |
| eIF3k | LmjF.32.2180 | 233 (26.3) | 28 (39) | 59 | Hypothetical protein, conserved |
| Tb927.11.15420 | 205 (23.1) | 25 (46) | 90 | Hypothetical protein, conserved | |
| eIF3l | LmjF.36.0250 | 633 (72.6) | 25 (45) | 65 | Eukaryotic translation initiation factor 3 subunit L, putative |
| Tb927.10.4640 | 488 (55.6) | 25 (43) | 87 | Eukaryotic translation initiation factor 3 subunit L, putative | |
In addition, a comparison against H. sapiens eIF3 subunits was performed.
1In the TriTrypDB database the AUG from these sequences were likely misidentified since they generate peptides missing from orthologues in related species and were removed here.
2The Identity (Similarity) levels for this protein were not significant and were omitted from the table.
Figure 1Conserved and diverged features between the trypanosomatid EIF3As and various eukaryotic orthologues. A Schematic representation of T. brucei EIF3A highlighting the PCI and Spectrin domains (red and blue boxes, respectively). B Amino acid sequence alignment comparing the N-terminus and the PCI and Spectrin domains from the various eIF3a homologues selected for this study. Amino acids identical in more than 60% of the sequences are shown with a blue background, while amino acids defined as similar, based on the BLOSUM 62 Matrix, in more than 60% of the sequences are highlighted with a green background. The red and blue lines define the PCI and Spectrin domains, respectively, whilst the yellow line indicates the segment implicated in the binding of human eIF3a to eIF3b and eIF3i [36]. The conserved residues within the Spectrin domain mentioned in the text are marked with “+”, whilst the “#” symbol marks the position of the conserved phenylalanine residue required for the interaction with human eIF3b.
Figure 2Conserved and diverged features between eIF3b orthologues from various protozoan and multicellular organisms. A Schematic representation of T. brucei EIF3B. The RRM and WD domains and the putative eIF3i binding region are indicated by red, green and blue boxes, respectively. B Amino acid sequence alignment comparing the RRM and WD domains and eIF3i binding region from eIF3b homologue from various protozoan and multicellular eukaryotes. The alignment was carried out as described for Figure 1 and the three segments analyzed are indicated by the red, green and blue lines, respectively. The “#” symbol marks the position of the conserved aromatic residue required for the interaction with yeast eIF3i [44], whilst the position of other residues seen to be involved in the interaction of eIF3b with eIF3i in yeast are indicated by the “+” symbol.
Figure 3Conserved elements at the N-terminal ends of eIF3c orthologues. A Schematic representation of T. brucei EIF3C. The regions homologous to the eIF5 and eIF1 binding regions from yeast eIF3c and the PCI domain are indicated by red, blue and green boxes, respectively. B Amino acid sequence alignment comparing the putative eIF5 and eIF1 binding regions of eIF3c (according to [46]), carried out as described for Figure 1. The two regions are indicated by red and blue lines, respectively, and conserved positions are marked with the “+” symbol.
Figure 4Conservation of the human Nuclear Export Signal (NES) within various eIF3e orthologues. A Schematic representation of T. brucei EIF3E. The NES and PCI domain are indicated by blue and red boxes, respectively. B Amino acid sequence alignment comparing the previously described NES, mapped to the very N-terminus of human eIF3e, and neighboring sequences, with similar sequences from trypanosomatids and other EIF3E orthologues.
Figure 5Evolutionary relationship of the protozoan MPN containing proteins. Maximum Likelihood tree based on the alignment of the MPN containing subunits from eIF3, proteasome and signalosome complexes from different eukaryotes, and the different MPN containing proteins identified in L. major, T. brucei, T. vaginalis and G. duodenalis. Bootstrap values are shown next to the respective branches (1,000 replicates).
Figure 6Evolutionary relationship of selected eIF3i orthologues and conservation of the its eIF3b and eIF3g interacting elements. A Maximum Likelihood tree based on the alignment of several eIF3i orthologues plus WD containing proteins from various protozoan and multicellular eukaryotes. B Schematic representation of T. brucei EIF3I. The position of the segment implicated in the binding to eIF3b [44] is indicated by a blue box. C Amino acid sequence alignment comparing the C-terminal half of eIF3i orthologues from the organisms selected for this study. The alignment was carried out as described for the previous figures. Residues seen to be involved in the interaction of eIF3i with eIF3b in yeast [44] are indicated by the “+” symbol, whilst residues which, when mutated, interfered in the interaction with eIF3g [43] are marked with “#”.
Figure 7Biochemical characterization of EIF3. A Subcellular localization of Leishmania EIF3E. The experiment was carried out through indirect immunofluorescence using the affinity purified anti-EIF3E antibodies. Where indicated, the cells were counterstained with TOTO-3 to locate the nuclear and kinetoplast DNA. B Immunoprecipitation (IP) of native EIF3E. IP reactions were set up using total L. infantum cytoplasmic extract and the affinity purified antibodies directed against Leishmania EIF3E, as well as the respective pre-immune control serum (IP Control). Precipitated immunocomplexes were then used in Western blot assays with the same anti-EIF3E antibodies used for the IP. C Summary of the mass-spectrometry analysis of the precipitated samples. A total of 13 polypeptides are shown which were specifically co-precipitated with the anti-EIF3E antibodies. The parameters shown in the table used to determine specificity for the IP reactions using the anti-EIF3E antibodies, always compared with the control IPs, are described in the Methods section. EIF1: translation initiation factor sui1. G6PD: Glucose-6-Phosphate 1-Dehydrogenase.